🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

Lipidor Ab (LIPI)

Stockholm
Currency in SEK
Disclaimer
0.13
0.00(0.00%)
Closed
LIPI Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
0.120.14
52 wk Range
0.040.50
Bid/Ask
0.13 / 0.13
Prev. Close
0.13
Open
0.13
Day's Range
0.12-0.14
52 wk Range
0.04-0.5
Volume
6,795,926
Average Volume (3m)
8,787,133
1-Year Change
-51.18%
Fair Value
Unlock
Fair Value Upside
Unlock
LIPI Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year
Show more

Lipidor Ab Company Profile

Lipidor AB (publ), a pharmaceutical development company, engages in the development of drugs for the treatment of psoriasis, acne vulgaris, bacterial skin infections, and atopic dermatitis. The company develops AKP-01, which is in Phase III for the treatment of psoriasis; and preclinical stage products, such as AKP-02 for psoriasis, AKP-03 for bacterial skin diseases, and AKP-07 for atopic dermatitis. It offers active pharmaceutical ingredients used in products for various therapeutic applications, such as anti-psoriasic, antimicrobial, anti-inflammatory, antifungal, local anesthetics, non-steroidal anti-inflammatory, anti-acne, wound healing, anti-eczema, and anti-migraine. The company also develops a range of spray products for animal skin care in dogs, cats, and horses; and consumer health care products for applications, including antibacterial, antiseptic, moisturizing emollient, disinfectant, and acne and wart treatment. It has a collaboration agreement with Cannassure Therapeutics Ltd. for the development of topical medicinal cannabis products for the treatment of skin inflammations and psoriatic lesions. The company was incorporated in 2009 and is based in Danderyd, Sweden.

Employees
6
Market
Sweden

Compare LIPI to Peers and Sector

Metrics to compare
LIPI
Peers
Sector
Relationship
P/E Ratio
−7.8x−5.7x−0.6x
PEG Ratio
−0.13−0.140.00
Price/Book
6.5x6.5x2.6x
Price / LTM Sales
1,137.0x16.0x3.2x
Upside (Analyst Target)
-78.6%41.1%
Fair Value Upside
Unlock−6.2%5.9%Unlock

FAQ

What Is the Lipidor (LIPI) Stock Price Today?

The Lipidor stock price today is 0.13

What Stock Exchange Does Lipidor Trade On?

Lipidor is listed and trades on the Stockholm stock exchange.

What Is the Stock Symbol for Lipidor?

The stock symbol for Lipidor is "LIPI."

What Is the Lipidor Market Cap?

As of today, Lipidor market cap is 102.90M.

What is Lipidor Earnings Per Share?

The Lipidor EPS is -0.342.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.